[Experiences on in vitro testing of cytostatic sensitivity (oncobiogram) in gynecological tumors].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004351:Drug Resistance; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D005833:Genital Neoplasms, Female / Q000188:drug therapy*; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D010051:Ovarian Neoplasms / Q000188:drug therapy; D012075:Remission, Spontaneous; D014228:Triaziquone / Q000627:therapeutic use; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy; D014594:Uterine Neoplasms / Q000188:drug therapy; D014747:Vinblastine / Q000627:therapeutic use; D014846:Vulvar Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D014747:Vinblastine; D003520:Cyclophosphamide; D014228:Triaziquone; D005472:Fluorouracil; D008727:Methotrexate
Erfahrungen mit dem Onkobiogramm bei gynäkologischen Karzinomen.